| Literature DB >> 30035823 |
Andrei Santos Siqueira1, Alex Ranieri Jerônimo Lima1, Delia Cristina Figueira Aguiar1, Alberdan Silva Santos2, João Lídio da Silva Gonçalves Vianez Júnior3, Evonnildo Costa Gonçalves1.
Abstract
Lectins are proteins of nonimmune origin, which are capable of recognizing and binding to glycoconjugate moieties. Some of them can block the interaction of viral glycoproteins to the host cell receptors acting as antiviral agents. Although cyanobacterial lectins have presented broad biotechnological potential, little research has been directed to Amazonian Cyanobacterial diversity. In order to identify new antiviral lectins, we performed genomic analysis in seven cyanobacterial strains from Coleção Amazônica de Cianobactérias e Microalgas (CACIAM). We found 75 unique CDS presenting one or more lectin domains. Since almost all were annotated as hypothetical proteins, we used homology modeling and molecular dynamics simulations to evaluate the structural and functional properties of three CDS that were more similar to known antiviral lectins. Nostoc sp. CACIAM 19 as well as Tolypothrix sp. CACIAM 22 strains presented cyanovirin-N homologues whose function was confirmed by binding free energy calculations. Asn, Glu, Thr, Lys, Leu, and Gly, which were described as binding residues for cyanovirin, were also observed on those structures. As for other known cyanovirins, those residues in both our models also made favorable interactions with dimannose. Finally, Alkalinema sp. CACIAM 70d presented one CDS, which was identified as a seven-bladed beta-propeller structure with binding sites predicted for sialic acid and N-acetylglucosamine. Despite its singular structure, our analysis suggested this molecule as a new putative antiviral lectin. Overall, the identification and the characterization of new lectins and their homologues are a promising area in antiviral research, and Amazonian cyanobacteria present biotechnological potential to be explored in this regard.Entities:
Keywords: Amazonia; antiviral lectins; cyanobacteria; cyanovirin; molecular dynamics
Mesh:
Substances:
Year: 2018 PMID: 30035823 PMCID: PMC7167734 DOI: 10.1002/prot.25577
Source DB: PubMed Journal: Proteins ISSN: 0887-3585
Results of genomic screening showing the number of CDSs predicted with lectins domains
| Strain | Sequences | Smaller | Largest |
|---|---|---|---|
|
| 2 | 177 aa | 264 aa |
|
| 4 | 219 aa | 1257 aa |
|
| 9 | 289 aa | 1652 aa |
|
| 20 | 61 aa | 1267 aa |
|
| 24 | 128 aa | 1480 aa |
|
| 4 | 358 aa | 784 aa |
|
| 22 | 99 aa | 1507 aa |
Figure 1– Structural alignment of Nostoc sp. CACIAM 19 cyanovirin and its template (a) and Tolypothrix sp. CACIAM 22 cyanovirin and its template (B) [Color figure can be viewed at http://wileyonlinelibrary.com]
Figure 2– (A) Alkalinema sp. CACIAM 70d lectin model showing two regions predicted as putative binding sites. (B) Electrostatic surface of the model showing the cavities predicted by COACH. Sialic acid binding sites are on the left and N‐acetylglucosamine binding sites are at the center [Color figure can be viewed at http://wileyonlinelibrary.com]
– Models identification and validation. Ramachandran values show the residues in favorable regions. SignalP server was used to predict the presence of signal peptide (http://www.cbs.dtu.dk/services/SignalP)
| Model | Ramachandran | Verify3D | Qmean | Signal P | Domain | Annotation |
|---|---|---|---|---|---|---|
|
| 96.5% | 100.0% | −2.87 | Yes | VCBS | Hypothetical protein |
|
| 96.0% | 100.0% | −1.12 | Yes | CVNH | Cyanovirin‐N (CV‐N) |
|
| 94.9% | 89.4% | 0.39 | No | CVNH | Hypothetical protein |
Figure 3– RMSD graphs of MD simulations. (A) 100 ns refinement simulation of the models. (B) 210 ns simulation of Nostoc sp. CACIAM 19 cyanovirin complexed with MAN–MAN. (C) 210 ns simulation of Tolypothrix sp. CACIAM 22 cyanovirin complexed with MAN–MAN
Figure 4– Final coordinates of MD simulation of (A) Nostoc ellipsosporum (1 N02) template cyanovirin, (B) Cyanothece sp. PCC 7424 (5 K79) template cyanovirin, (C) Tolypothrix sp. CACIAM 22 model cyanovirin, and (D) Nostoc sp. CACIAM 19 model cyanovirin. The residues labeled were the ones most important to the binding process according to the binding free energy calculations
– Bind free energy calculations results based on last 10 ns of MD simulation. All energy values are in kcal Mol−1
| MM‐GBSA | Std. dev. | Std. error | MM‐PBSA | Std. dev. | Std. error | SIE | Std. dev. | Std. error | |
|---|---|---|---|---|---|---|---|---|---|
|
| −35.02 | 4.41 | 0.14 | −31.88 | 5.74 | 0.18 | −7.97 | 0.41 | 0.03 |
|
| −26.74 | 3.61 | 0.11 | −30.50 | 3.60 | 0.11 | −7.59 | 0.33 | 0.02 |
|
| −31.31 | 3.39 | 0.11 | −31.97 | 3.58 | 0.11 | −7.93 | 0.30 | 0.02 |
|
| −18.01 | 2.91 | 0.09 | −19.75 | 3.20 | 0.10 | −6.85 | 0.25 | 0.02 |
Figure 5– Individual energy contribution by residues according to the MM‐GBSA method in cyanovirin‐ligand complexation [Color figure can be viewed at http://wileyonlinelibrary.com]